NewLimit CEO Says AI Marks Biotech's Biggest Shift in 40 Years

Jacob Kimmel, CEO of NewLimit, stated that artificial intelligence represents biotech's largest transformation in over 40 years. The comment appeared in a retweet of a post quoting him directly on the topic. The visible exchange on X references the claim alongside a comparison to earlier advances such as recombinant DNA. No further details on the reasons behind the assessment or reactions appear in the supplied posts.